
Loading, please wait...

Loading, please wait...

Modern clinical practice relies heavily on portable and implantable electronic devices. Consequently, the demand for safe, high-performance energy storage is rising. Researchers recently unveiled a breakthrough in solid-state proton batteries using graphdiyne oxide (GDYO), which could redefine how we power medical technology.
This research addresses a major hurdle in battery science: low conductivity in solid electrolytes at room temperature. Specifically, the team constructed a three-dimensional hydrogen bonding network by combining GDYO with phosphoric acid. Furthermore, this GDYO@HPO4 electrolyte facilitates efficient proton transport through a sophisticated hopping mechanism.
Safety is paramount in medical applications, especially for internal devices like pacemakers. Notably, these batteries eliminate the need for flammable liquid electrolytes. Therefore, they offer a safer alternative for patients. Moreover, the assembled full solid-state battery demonstrated an ultrahigh charge-discharge rate of 50C, retaining over 50% capacity.
Longevity is another critical factor for implantable technology. Additionally, this system showed remarkable cycling stability, maintaining 90.2% capacity even after 4500 cycles. In contrast to current lithium-ion systems, these proton-based batteries could significantly extend the lifespan of life-saving medical devices.
Ultimately, the molecular-level design of GDYO provides a robust platform for advanced electrocatalysts. This research paves the way for high-performance, long-lasting energy solutions in healthcare.
Solid-state proton batteries use hydrogen ions as charge carriers and solid electrolytes. This design is generally safer and more stable than the liquid-based lithium-ion batteries found in many current portable devices.
A high charge rate allows medical devices to recharge rapidly. This feature is essential for emergency equipment and portable diagnostics that require immediate readiness in clinical settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always seek the advice of a physician or other qualified health provider regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Huang Y et al. Graphdiyne Oxide-Enabled Solid-State Proton Battery Exhibiting Superior Rate Capability. Angew Chem Int Ed Engl. 2026 Jun 20. doi: 10.1002/anie.4266547. PMID: 42322151.
2. ANSTO. A breakthrough in all-organic proton batteries for safer, sustainable energy storage. 2025.
3. Jiang W et al. Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets. Nano Lett. 2019.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A novel solid-state proton battery using graphdiyne oxide (GDYO) offers ultra-high charge rates and exceptional stability, paving the way for safer and more efficient medical devices.
last month

Researchers at Kyushu University have uncovered a novel compound, lipoic acid trisulfide (LASSS), that enhances hepatocyte growth factor (HGF) signaling and protects against nitration-induced protein dysfunction, presenting a potential breakthrough for age-related muscle atrophy and sarcopenia.
Yesterday

A study identifies a critical hypospadias gene-environment interaction. Research shows that the risk gene DNAH8 and DEHP exposure combine to disrupt steroidogenesis and mesenchymal progenitor cell differentiation, significantly increasing the risk of severe urethral malformations in male fetuses.
5 days back

A pre-clinical study reveals that elevated serum pro-N-cadherin levels correlate strongly with severe cardiac fibrosis and diastolic dysfunction following radiation exposure, promising a potential early biomarker for radiation-related heart disease.
3 days back

Discover how biophysical forces shape tissue formation and regeneration. This review explores mechanotransduction in tissue development, from molecular sensors like integrins to tissue-scale flows, highlighting critical implications for regenerative medicine and functional organoid engineering.
Last week

A groundbreaking study utilizes single-cell RNA sequencing to map the tumor microenvironment of ovarian steroid cell tumors-not otherwise specified (SCT-NOS), identifying key steroidogenic subtypes and immune cell distributions that drive hyperandrogenism and tumor progression.
Last week